 |
||||||||
 |
|
 |
 |
 |
 |
 |
|
|
 |
Ablynx (Belgium) is engaged in the discovery and
development of Nanobodies, a novel class of therapeutic proteins
based on single-domain antibody fragments, for a range of serious human
diseases including inflammation, thrombosis, oncology and Alzheimer's
disease. http://www.ablynx.com/ |
|
Addex (Switzerland) discovers and develops novel
therapeutics which modulate the effect of natural activators of G-protein
coupled receptors on their specific targets. These allosteric modulators
offer the potential for novel, more selective and safer treatments for CNS
and other disorders. http://www.addexpharma.com/ |
|
OctoPlus NV (Netherlands)provides formulation
services and develops proprietary products employing its patented
implantable polymer microspheres for controlled drug delivery. http://www.octoplus.nl/ | 
|
RedPoint Bio. (USA) develops gustation solutions, with a
focus on products to improve bitter flavors and treatments for taste dysfunction. http://www.redpointbio.com/ |